Nosebleed (Epistaxis)

Authoring Organization

Endorsing Organizations

Publication Month/Year

January 7, 2020

Last Updated Month/Year

February 20, 2024

Document Type


External Publication Status


Country of Publication


Document Objectives

For the purposes of this guideline, we define the target patient with a nosebleed as a patient with bleeding from the nostril, nasal cavity, or nasopharynx that is sufficient to warrant medical advice or care. This includes bleeding that is severe, persistent, and/or recurrent, as well as bleeding that impacts a patient’s quality of life. Interventions for nosebleeds range from self-treatment and home remedies to more intensive procedural interventions in medical offices, emergency departments, hospitals, and operating rooms. 

Target Patient Population

Any individual aged ≥3 years with a nosebleed or history of nosebleed who needs medical treatment or seeks medical advice

Target Provider Population

Clinicians who evaluate and treat patients with nosebleed

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory, Childcare center, Emergency care, School

Intended Users

Nurse, nurse practitioner, physician, physician assistant


Diagnosis, Treatment, Management, Prevention

Diseases/Conditions (MeSH)

D004844 - Epistaxis


epistaxis, nosebleed, nasal packing, nasal cautery, hereditary hemorrhagic telangiectasia (HHT)

Source Citation

Tunkel, D. E., Anne, S., Payne, S. C., Ishman, S. L., Rosenfeld, R. M., Abramson, P. J., … Monjur, T. M. (2020). Clinical Practice Guideline: Nosebleed (Epistaxis). Otolaryngology–Head and Neck Surgery, 162(1_suppl), S1–S38. https://doi.org/10.1177/0194599819890327

Supplemental Methodology Resources

Data Supplement